Skip to main content
. 2019 Sep 10;15:2613–2620. doi: 10.2147/NDT.S207580

Table 1.

Review of publications finally included in the full-text analysis

Publication n n studied group (girls) n g. control (girls) Diagnosis Participants’ age M (SD) Conclusion Materials and methods Publication’s evaluationd
Taurines et al, 201412 36 19 17 DSM; ADI-R; ADOS 10.7 (3.8) years OXT in the ASD group (p=0.132)b Plasma
RIA
8
Modahl et al, 199831 59 29 30 DSM 8.08 (1.6) years OXT in the ASD groupc Plasma
RIA
6.5
Alabdali et al, 201432 80 50 30 DSM 7.0 (2.34) years OXT in the ASD groupc Plasma
ELISA
6
Green et al, 200133 59 28 31 DSM 8.08 (1.6) years
5.8–11.58 years
OXT in the ASD groupc Plasma
RIA
5.5
Al-Ayadhi 200519 154 77 (6) 77 (6) DSM 3.5–14 years OXT in the ASD groupc
AVP in the ASD groupc
Plasma
ELISA
4
Abdulamir et al, 201634 86 60 26 DSM 7.28 (2.89) years OXT in the ASD groupc Plasma
ELISA
6
Althaus et al, 201615 61 31 30 DSM 22.67 (422) years
18–34 years
OXT in the ASD group (p=0.05)b Plasma
RIA
7.5
Boso et al, 200720 39 18 (2) 21 (3) DSM 27.5 (7.2) years
15–42 years
AVP in the ASD groupa Plasma
ELISA
5
Zhang et al, 201617 169 84 (13) 85 (14) DSM 3.95 (1.26) years
2–7 years
OXT in the ASD groupc
AVP in the ASD group (p=0.477)b
Plasma
ELISA
7.5
Carson et al, 201521 112 57 (9) 55 (19) DSM; ADI-R; ADOS 8.58 (0.45) years No differences between the groups (AVP; p>0.05) Plasma
ELISA
6
Miller et al, 201311 75 40 (19) 35 (16) DSM; ADI-R; ADOS 8–18 years No differences between the groups (OXT; p>0.05)
No differences between the groups (AVP; p>0.05)
Plasma
ELISA
7.5
Jacobson et al, 201416 78 37 (12) 41 (17) DSM; ADI-R; ADOS 4.73 (0.61) years OXT in the ASD groupa Plasma
ELISA
8

Notes: aIncreased level; bIncreased level but statistically insignificant result; cDecreased level. dAccording to the Newcastle–Ottawa Quality Assessment Scale for Case Control Studies – max 9 pkt.

Abbreviations: DSM, diagnostic and statistical manual of mental disorders IV-TR; ADI-R, autism diagnostic interview – reviewed; ADOS, autism diagnostic and observation schedule; OXT, oxytocin; ASD, autism spectrum disorde; ELISA, enzyme-linked immunorbent assay; AVP, arginine-vasopressin.